Dapsone is a common medication that is utilized in the treatment of dermatological conditions, pneumocystis pneumonia, and toxoplasmosis. Methemoglobinemia is a known but rare complication of dapsone therapy that can result in cyanosis. We present a case of a patient on dapsone therapy who developed hypoxia due to methemoglobinemia. This case emphasizes the importance of knowledge of drugs likely to cause methemoglobinemia which requires clinicians to have a high degree of suspicion especially when the patient's oxygen saturation does not improve with treatment.
CITATION STYLE
Keerty, D., Eaton, K., & Haynes, E. (2020). Dapsone-Induced Hypoxia. Cureus. https://doi.org/10.7759/cureus.9334
Mendeley helps you to discover research relevant for your work.